Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 4,088,056,000
  • Market Capitalization, $K 4,088,056
  • Shares Outstanding, K 51,800
  • 36-Month Beta 1.50
  • Price/Book N/A
  • Price/Earnings ttm 22.01
  • Annual Dividend & Yield 0.23 (0.28%)
  • Most Recent Dividend 0.073 on 09/21/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.97 +5.27%
on 11/14/18
85.33 -8.74%
on 12/04/18
+0.59 (+0.76%)
since 11/13/18
3-Month
73.97 +5.27%
on 11/14/18
97.60 -20.22%
on 09/26/18
-18.03 (-18.80%)
since 09/13/18
52-Week
73.97 +5.27%
on 11/14/18
101.55 -23.32%
on 06/21/18
-5.05 (-6.09%)
since 12/13/17

Most Recent Stories

More News
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 49.51 (-1.71%)
ILMN : 334.62 (-0.68%)
IBB : 103.89 (-1.51%)
VRTX : 173.42 (-1.16%)
AMGN : 197.53 (+0.57%)
XBI : 77.87 (-2.76%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 49.51 (-1.71%)
IBB : 103.89 (-1.51%)
VRTX : 173.42 (-1.16%)
AMGN : 197.53 (+0.57%)
XBI : 77.87 (-2.76%)
BIIB : 320.14 (-0.77%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 49.51 (-1.71%)
IBB : 103.89 (-1.51%)
VRTX : 173.42 (-1.16%)
REGN : 378.51 (+0.15%)
AMGN : 197.53 (+0.57%)
XBI : 77.87 (-2.76%)
Trump's Approval Rises Before Midterms: ETFs to Lose/Gain

Recent improvement in Trump's approval rating puts these ETFs in focus.

FXU : 28.81 (+0.31%)
FXI : 41.59 (+0.80%)
PKB : 24.59 (-1.44%)
ITA : 184.68 (-0.76%)
XBI : 77.87 (-2.76%)
KRE : 49.45 (-2.70%)
Trump's Approval Rises Before Midterms: ETFs to Lose/Gain

Recent improvement in Trump's approval rating puts these ETFs in focus.

FXU : 28.81 (+0.31%)
FXI : 41.59 (+0.80%)
PKB : 24.59 (-1.44%)
ITA : 184.68 (-0.76%)
XBI : 77.87 (-2.76%)
KRE : 49.45 (-2.70%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 49.51 (-1.71%)
ILMN : 334.62 (-0.68%)
IBB : 103.89 (-1.51%)
VRTX : 173.42 (-1.16%)
AMGN : 197.53 (+0.57%)
XBI : 77.87 (-2.76%)
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 49.51 (-1.71%)
ILMN : 334.62 (-0.68%)
IBB : 103.89 (-1.51%)
QGEN : 35.02 (-0.11%)
XBI : 77.87 (-2.76%)
BIIB : 320.14 (-0.77%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 25.98 (-3.42%)
CNCR : 20.68 (-1.52%)
IBB : 103.89 (-1.51%)
PSCH : 119.25 (-2.15%)
XBI : 77.87 (-2.76%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 25.98 (-3.42%)
CNCR : 20.68 (-1.52%)
IBB : 103.89 (-1.51%)
PSCH : 119.25 (-2.15%)
XBI : 77.87 (-2.76%)
Strong Week Despite Weak Finish

Strong Week Despite Weak Finish

YY : 65.57 (+0.08%)
CPA : 77.40 (-3.19%)
INTT : 6.60 (-2.80%)
SNE : 52.20 (-0.80%)
XBI : 77.87 (-2.76%)
AMZN : 1,658.38 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 81.64
1st Resistance Point 79.75
Last Price 77.87
1st Support Level 76.84
2nd Support Level 75.82

See More

52-Week High 101.55
Fibonacci 61.8% 91.01
Fibonacci 50% 87.76
Fibonacci 38.2% 84.51
Last Price 77.87
52-Week Low 73.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar